Immunohistochemical analysis of tissue samples from our ICGC‐ARGO cohort, consisting of 30 CRC patients, demonstrated detectable expression of CDKN1A, CDKN2A, CBX7, and SIRT1 using specific antibodies (Figure 6D,E). This evidence concerns the gene CDKN1A and colorectal carcinoma.